322 related articles for article (PubMed ID: 12736097)
1. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
Odaka M; Koga M; Yuki N; Susuki K; Hirata K
J Neurol Sci; 2003 Jun; 210(1-2):99-103. PubMed ID: 12736097
[TBL] [Abstract][Full Text] [Related]
2. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
3. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
4. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
Koga M; Yuki N; Hirata K
J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
6. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
7. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
8. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
9. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
10. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
[TBL] [Abstract][Full Text] [Related]
11. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
Koga M; Takahashi M; Yokoyama K; Kanda T
J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
[TBL] [Abstract][Full Text] [Related]
12. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
13. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.
Yuki N; Taki T; Handa S
J Neuroimmunol; 1996 Dec; 71(1-2):155-61. PubMed ID: 8982115
[TBL] [Abstract][Full Text] [Related]
14. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
15. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
16. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
Yuki N
Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
[TBL] [Abstract][Full Text] [Related]
17. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
[TBL] [Abstract][Full Text] [Related]
18. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
[TBL] [Abstract][Full Text] [Related]
20. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]